JP2012021008A5 - - Google Patents

Download PDF

Info

Publication number
JP2012021008A5
JP2012021008A5 JP2011179648A JP2011179648A JP2012021008A5 JP 2012021008 A5 JP2012021008 A5 JP 2012021008A5 JP 2011179648 A JP2011179648 A JP 2011179648A JP 2011179648 A JP2011179648 A JP 2011179648A JP 2012021008 A5 JP2012021008 A5 JP 2012021008A5
Authority
JP
Japan
Prior art keywords
microparticles
less
pharmaceutical composition
enteric coating
acid labile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011179648A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012021008A (ja
Filing date
Publication date
Priority claimed from US10/190,242 external-priority patent/US20040005362A1/en
Application filed filed Critical
Publication of JP2012021008A publication Critical patent/JP2012021008A/ja
Publication of JP2012021008A5 publication Critical patent/JP2012021008A5/ja
Withdrawn legal-status Critical Current

Links

JP2011179648A 2002-07-03 2011-08-19 酸不安定性薬物の液体剤形 Withdrawn JP2012021008A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/190,242 2002-07-03
US10/190,242 US20040005362A1 (en) 2002-07-03 2002-07-03 Liquid dosage forms of acid labile drugs

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004519788A Division JP2005533832A (ja) 2002-07-03 2003-07-02 酸不安定性薬物の液体剤形

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015021882A Division JP5997788B2 (ja) 2002-07-03 2015-02-06 酸不安定性薬物の液体剤形

Publications (2)

Publication Number Publication Date
JP2012021008A JP2012021008A (ja) 2012-02-02
JP2012021008A5 true JP2012021008A5 (enExample) 2012-08-02

Family

ID=29999830

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2004519788A Pending JP2005533832A (ja) 2002-07-03 2003-07-02 酸不安定性薬物の液体剤形
JP2011179648A Withdrawn JP2012021008A (ja) 2002-07-03 2011-08-19 酸不安定性薬物の液体剤形
JP2015021882A Expired - Fee Related JP5997788B2 (ja) 2002-07-03 2015-02-06 酸不安定性薬物の液体剤形
JP2016049674A Expired - Fee Related JP6209237B2 (ja) 2002-07-03 2016-03-14 酸不安定性薬物の液体剤形
JP2017115697A Pending JP2017206525A (ja) 2002-07-03 2017-06-13 酸不安定性薬物の液体剤形

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004519788A Pending JP2005533832A (ja) 2002-07-03 2003-07-02 酸不安定性薬物の液体剤形

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2015021882A Expired - Fee Related JP5997788B2 (ja) 2002-07-03 2015-02-06 酸不安定性薬物の液体剤形
JP2016049674A Expired - Fee Related JP6209237B2 (ja) 2002-07-03 2016-03-14 酸不安定性薬物の液体剤形
JP2017115697A Pending JP2017206525A (ja) 2002-07-03 2017-06-13 酸不安定性薬物の液体剤形

Country Status (7)

Country Link
US (1) US20040005362A1 (enExample)
EP (1) EP1539156B8 (enExample)
JP (5) JP2005533832A (enExample)
CA (1) CA2490145C (enExample)
ES (1) ES2401102T3 (enExample)
MX (1) MXPA05000298A (enExample)
WO (1) WO2004004718A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040082618A1 (en) * 2002-07-03 2004-04-29 Rajneesh Taneja Liquid dosage forms of acid labile drugs
US20050220870A1 (en) * 2003-02-20 2005-10-06 Bonnie Hepburn Novel formulation, omeprazole antacid complex-immediate release for rapid and sustained suppression of gastric acid
US8993599B2 (en) * 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MXPA06000524A (es) * 2003-07-18 2006-08-11 Santarus Inc Formulacion farmaceutica y metodo para tratar desordenes gastrointestinales provocados por acido.
CA2531564C (en) * 2003-07-18 2016-01-19 Santarus, Inc. Pharmaceutical composition for inhibiting acid secretion
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
AU2005213472A1 (en) * 2004-02-10 2005-08-25 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and nonsteroidal anti-inflammatory agent
AU2005249367A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) * 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20060134210A1 (en) * 2004-12-22 2006-06-22 Astrazeneca Ab Solid dosage form comprising proton pump inhibitor and suspension made thereof
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP3079748B1 (en) * 2013-12-12 2020-05-27 Hollister Incorporated Flushable disintegration catheter
JP6122815B2 (ja) * 2014-02-20 2017-04-26 ライオン株式会社 経口製剤及びその製造方法
EP3117824A1 (en) * 2015-07-17 2017-01-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
BE1024339B1 (fr) * 2016-07-01 2018-01-29 Be Pharbel Mfg Sa Microparticules multicouches libérant un composé pharmaceutiquement actif dans une forme pharmaceutique liquide
US12472149B2 (en) 2015-07-17 2025-11-18 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form
US20190008787A1 (en) * 2015-07-17 2019-01-10 BE Pharbel Manufacturing Multilayered pharmaceutically active compound-releasing microparticles in a liquid dosage form

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
US4808411A (en) * 1987-06-05 1989-02-28 Abbott Laboratories Antibiotic-polymer compositions
US5464632C1 (en) * 1991-07-22 2001-02-20 Prographarm Lab Rapidly disintegratable multiparticular tablet
FR2679451B1 (fr) * 1991-07-22 1994-09-09 Prographarm Laboratoires Comprime multiparticulaire a delitement rapide.
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
JPH06319496A (ja) * 1993-05-11 1994-11-22 Seiichi Kudo リンゴジュース
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
SE512835C2 (sv) * 1996-01-08 2000-05-22 Astrazeneca Ab Doseringsform innehållande en mångfald enheter alla inneslutande syralabil H+K+ATPas-hämmare
TW580397B (en) * 1997-05-27 2004-03-21 Takeda Chemical Industries Ltd Solid preparation
JP4939680B2 (ja) * 1997-05-27 2012-05-30 武田薬品工業株式会社 固形製剤
EP1051087A2 (en) * 1998-01-30 2000-11-15 Flow International Corporation Method for ultra high pressure inactivation of microorganisms in juice products
WO1999059544A2 (en) * 1998-05-18 1999-11-25 Takeda Chemical Industries, Ltd. Orally disintegrable tablets
JP4980527B2 (ja) * 1999-06-07 2012-07-18 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸に不安定な活性化合物を含有する新規の製剤および投与形
JP5009482B2 (ja) * 2000-12-07 2012-08-22 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング 酸に不安定な活性成分を含有する懸濁液の形の製薬製剤

Similar Documents

Publication Publication Date Title
JP2012021008A5 (enExample)
HUS2100018I1 (hu) Hatóanyagok légúti beadására alkalmas készítmények és ezekkel kapcsolatos eljárások
JP2012126725A5 (enExample)
HUE048597T2 (hu) Módszer polimerbevonatú fehérje-mikrorészecskéket tartalmazó, elnyújtott hatóanyag-kibocsátású gyógyszerészeti készítmény gyártására porlasztva szárítással
EP2658527A4 (en) NANOPARTICLES AND SURFACE-MODIFIED PARTICLE COATINGS, COATED BALLOONS AND METHOD THEREFOR
JP2013523703A5 (enExample)
JP2016533322A5 (enExample)
JP2011256183A5 (enExample)
EP2019665A4 (en) DRUG DISPERSION OF CAPSULES COVERED WITH NANOTEILS
EP2726975A4 (en) ACTIVATION PROCEDURE FOR A STORAGE GATEWAY
HUE036220T2 (hu) Kinazolin származékok vírusfertõzések és további betegségek kezelésére
JP2014513036A5 (enExample)
JP2015501646A5 (enExample)
JP2014516397A5 (enExample)
PL2230932T3 (pl) Powlekany preparat farmaceutyczny lub nutraceutyczny o zwiększonym uwalnianiu substancji aktywnej w jelicie grubym
DK2249866T3 (da) Anvendelse af et acetylsalicylsyresalt til behandlingen af virusinfektioner
JP2011137005A5 (enExample)
JP2013540702A5 (enExample)
HRP20191348T1 (hr) Aminosteroidi za liječenje bolesti povezanih s ptp1b
JP2011251985A5 (enExample)
JP2015508411A5 (enExample)
JP2011236418A5 (enExample)
EP2716290A4 (en) DRY-COATED TABLET WITH TEGAFUR, GIMERACIL AND OTERACIL CALIUM
EP2452678A3 (en) Pulsatile-release pharmaceutical formulation of dexlansoprazole
JP2011251959A5 (enExample)